Benefits
Glycemic Support
Cinnamon has documented effects on blood glucose; Gencinia standardization provides consistent dose-response. Mechanism: insulin-mimetic effects, glucose uptake enhancement.
Lipid Profile Effects
Cinnamon has modest effects on cholesterol and triglycerides in some trials.
Cardiovascular Markers
Polyphenol content provides cardiovascular benefit potential; oxidative stress reduction.
Standardized for Clinical Applications
Saanroo standardization ensures consistent active compound delivery.
Multiple Cinnamon Mechanisms in One Product
Cinnamon's effects involve insulin signaling, alpha-glucosidase inhibition, GLP-1 effects, antioxidant activity.
Mechanism of action
Insulin-Mimetic Effects
Cinnamon polyphenols (especially cinnamtannins B1) directly bind insulin receptor and modulate insulin signaling.
Alpha-Glucosidase Inhibition
Modest inhibition of carbohydrate-digesting enzymes — slows glucose absorption from meals.
Anti-Inflammatory and Antioxidant
Polyphenol fraction provides antioxidant and anti-inflammatory effects.
Lipid Metabolism Modulation
Cinnamon affects HMG-CoA reductase and lipid metabolism; modest lipid-lowering effects.
Clinical trials
Multiple cinnamon RCTs for blood glucose and metabolic markers.
T2D, prediabetes, healthy adults.
Modest reductions in fasting glucose, HbA1c, and metabolic markers; effects most consistent in T2D populations.
Saanroo clinical studies of Gencinia standardized cinnamon for metabolic applications.
Adults with metabolic concerns.
Improvements in metabolic markers.
About this ingredient
GENCINIA is a STANDARDIZED CINNAMON EXTRACT developed by SAANROO (formerly Gencor Pacific) — designed for METABOLIC HEALTH applications. CINNAMON BACKGROUND: bark from Cinnamomum trees; CEYLON CINNAMON has low coumarin; CASSIA CINNAMON has higher coumarin content.
KEY ACTIVES: PROANTHOCYANIDINS, CINNAMTANNINS (B-type PACs unique to cinnamon), polyphenols.
EVIDENCE-BASED USES: (1) GLYCEMIC SUPPORT; (2) Metabolic syndrome adjunct; (3) Lipid profile modest effects; (4) Cardiovascular markers; (5) Antioxidant/anti-inflammatory support.
CRITICAL CAUTIONS: (1) COUMARIN CONTENT — cassia cinnamon contains coumarin; potential hepatotoxin and anticoagulant at high doses; verify Gencinia coumarin specifications; (2) DIABETES MEDICATIONS — additive hypoglycemic effects; (3) ANTICOAGULANTS — coumarin theoretical interaction; (4) HEPATIC IMPAIRMENT — AVOID with significant liver disease; (5) PREGNANCY — culinary cinnamon safe; concentrated supplementation limited data; AVOID high-dose; (6) DOSE — per Saanroo specification; (7) GENCINIA vs INAVEA CINNAMON ACACIA — different positioning (Gencinia is cinnamon alone; inavea combines with acacia for dual mechanism); (8) METABOLIC HEALTH FRAMEWORK — comprehensive approach foundational; cinnamon one tool; (9) FOR PREDIABETES — modest cinnamon effects useful adjunct alongside lifestyle; not replacement for medical management of diabetes; (10) DURATION — glycemic effects modest but consistent over 4-12 weeks.